Effects of Antiviral Therapies on Epstein-Barr Virus Replication
Clinical trial NCT05957913 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05957913
- Sponsor
- Massachusetts General Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2027-06-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.